| Product Code: ETC8868221 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Neuroblastoma Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Neuroblastoma Market - Industry Life Cycle |
3.4 Poland Neuroblastoma Market - Porter's Five Forces |
3.5 Poland Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Poland Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Poland Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Poland Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in healthcare infrastructure in Poland |
4.2.2 Growing awareness about neuroblastoma among healthcare professionals and general population |
4.2.3 Advances in research and development leading to new treatment options for neuroblastoma patients |
4.3 Market Restraints |
4.3.1 Limited access to specialized treatment centers for neuroblastoma in Poland |
4.3.2 High treatment costs associated with neuroblastoma therapies |
4.3.3 Lack of reimbursement policies for expensive neuroblastoma treatments |
5 Poland Neuroblastoma Market Trends |
6 Poland Neuroblastoma Market, By Types |
6.1 Poland Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Poland Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Poland Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Poland Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Poland Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Poland Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Poland Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Poland Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Poland Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Poland Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Poland Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Poland Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Poland Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Poland Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Poland Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Poland Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Poland Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Poland Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Poland Neuroblastoma Market Import-Export Trade Statistics |
7.1 Poland Neuroblastoma Market Export to Major Countries |
7.2 Poland Neuroblastoma Market Imports from Major Countries |
8 Poland Neuroblastoma Market Key Performance Indicators |
8.1 Survival rate of neuroblastoma patients in Poland |
8.2 Number of clinical trials for neuroblastoma treatments conducted in Poland |
8.3 Adoption rate of innovative neuroblastoma therapies in the market |
9 Poland Neuroblastoma Market - Opportunity Assessment |
9.1 Poland Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Poland Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Poland Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Poland Neuroblastoma Market - Competitive Landscape |
10.1 Poland Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Poland Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here